Position in NAMS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$42,482,773
+$18,377,516 QoQ
Shares Held
1,253,549
+66.5% QoQ
Ownership
1.05%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#21
of 198 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 97%
None 3%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. NAMS ranks #21 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in NAMS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $42,482,773 | 1,253,549 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $24,105,257 | 753,054 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,341,596 | 152,269 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,133,099 | 145,327 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,768,346 | 208,081 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,947,802 | 95,154 | Shares | Defined | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||